- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 107.41M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $132.19M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $99.77M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $70.86M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $81.81M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $219.53M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $222.44M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $719.46M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $690.26M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.38B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.34B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 110.04M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $50.81M |
| Capex | Q1 2025 · Mar 31, 2024 | $3.01M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $39.12M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $991.59M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.04B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.30 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.30 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $25.83M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $37.36M |
| Net Income | Q1 2025 · Mar 31, 2024 | $32.9M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $30.13M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $94.21M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $23.66M |